secwatch.observer — SEC 8-K summary
======================================

Issuer:     Silo Pharma, Inc. (SILO)
CIK:        0001514183
Form:       8-K
Filed at:   2024-06-06T23:59:59+00:00
Accession:  0001213900-24-050405
Event type: other_material
Sentiment:  neutral
Materiality: 0.50
Item codes: 1.01, 3.02, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Silo Pharma raises $2M in registered direct offering with warrants
------------------------------------------------------------------

- Sold 917,432 shares at $2.18/share and issued warrants for 917,432 shares at $2.06 exercise price.
- Gross proceeds ~$2M; net proceeds for working capital and general corporate purposes.
- H.C. Wainwright acted as exclusive placement agent; fees include 7.5% cash fee and 68,807 warrant shares.
- Closing occurred June 6, 2024; warrants exercisable immediately for 5 years.
- Officers and directors subject to 15-day lock-up; company restricted from variable-rate transactions for one year.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1514183/000121390024050405/0001213900-24-050405-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1514183/000121390024050405/ea0207381-8k_silo.htm
  HTML page:      https://secwatch.observer/filing/0001213900-24-050405

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer